Pricing of innovative drugs: correlation between incremental cost and survival gain in four countries
Main Authors: | Daniele Mengato, Andrea Messori |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-07-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834016644465 |
Similar Items
-
Evaluating national pricing policies of innovative anti-cancer drugs: correlation analysis between costs and survival in 15 European countries
by: Daniele Mengato, et al.
Published: (2016-11-01) -
Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median
by: Andrea Messori, et al.
Published: (2020-06-01) -
Orphan Drug Pricing: An Original Exponential Model Relating Price to the Number of Patients
by: Andrea Messori
Published: (2016-10-01) -
Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors
by: Vera Damuzzo, et al.
Published: (2019-06-01) -
Long Run Incremental Cost Pricing for Use of Circuit Breakers
by: Li, Bo
Published: (2010)